189 related articles for article (PubMed ID: 719633)
21. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
Levine WG
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):113-20. PubMed ID: 6438741
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
[TBL] [Abstract][Full Text] [Related]
23. Neoplastic effects of oral administration of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and their inhibition by butylated hydroxyanisole.
Wattenberg LW; Jerina DM; Lam LK; Yagi H
J Natl Cancer Inst; 1979 Apr; 62(4):1103-6. PubMed ID: 285284
[TBL] [Abstract][Full Text] [Related]
24. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
Ioannou YM; Wilson AG; Anderson MW
Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
[TBL] [Abstract][Full Text] [Related]
25. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
26. Effects of administration to mice of butylated hydroxyanisole by oral intubation on benzo[a]pyrene-induced pulmonary adenoma formation and metabolism of benzo[a]pyrene.
Speier JL; Lam LK; Wattenberg LW
J Natl Cancer Inst; 1978 Mar; 60(3):605-9. PubMed ID: 625066
[TBL] [Abstract][Full Text] [Related]
27. Regioselective inhibition of benzo[a]pyrene metabolism by butylated hydroxyanisole.
Sydor W; Chou MW; Yang SK; Yang CS
Carcinogenesis; 1983; 4(2):131-6. PubMed ID: 6297821
[TBL] [Abstract][Full Text] [Related]
28. Dietary administration of 2(3)-t-butyl-4-hydroxyanisole elevates mouse liver microsome-mediated DNA binding and mutagenicity of aflatoxin B1.
Rahimtula AD; Martin M
Chem Biol Interact; 1984 Feb; 48(2):207-20. PubMed ID: 6421497
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of dietary administration of antioxidants and inducers on the activities of several hepatic enzymes in mice.
Cha YN; Heine HS; Ansher S
Drug Nutr Interact; 1983; 2(1):35-45. PubMed ID: 6678746
[TBL] [Abstract][Full Text] [Related]
30. Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N-nitrosodimethylamine and N-nitrosopyrrolidine in A/J mice.
Chung FL; Wang M; Carmella SG; Hecht SS
Cancer Res; 1986 Jan; 46(1):165-8. PubMed ID: 3940189
[TBL] [Abstract][Full Text] [Related]
31. Effects of dietary broccoli and butylated hydroxyanisole on liver-mediated metabolism of benzo[a]pyrene.
Aspry KE; Bjeldanes LF
Food Chem Toxicol; 1983 Apr; 21(2):133-42. PubMed ID: 6299911
[TBL] [Abstract][Full Text] [Related]
32. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone.
Lamb JG; Franklin MR
Drug Metab Dispos; 2000 Sep; 28(9):1018-23. PubMed ID: 10950843
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of (+/-)-trans-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in mouse liver microsomes and the effect of 2(3)-tert-butyl-4-hydroxy-anisole.
Dock L; Rahimtula A; Jernström B; Moldéus P
Carcinogenesis; 1982; 3(6):697-701. PubMed ID: 6889472
[TBL] [Abstract][Full Text] [Related]
34. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
Jhee EC; Ho LL; Lotlikar PD
Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
[TBL] [Abstract][Full Text] [Related]
35. Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
Hjelle JJ; Hazelton GA; Klaassen CD
Drug Metab Dispos; 1985; 13(1):68-70. PubMed ID: 2858380
[TBL] [Abstract][Full Text] [Related]
36. Effect of 2(3)-tert-butyl-4-hydroxyanisole on benzo[a]pyrene metabolism and DNA-binding of benzo[a]pyrene metabolites in isolated mouse hepatocytes.
Dock L; Cha YN; Jernström B; Moldéus P
Chem Biol Interact; 1982 Jul; 41(1):25-37. PubMed ID: 6284389
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes.
Cummings SW; Ansari GA; Guengerich FP; Crouch LS; Prough RA
Cancer Res; 1985 Nov; 45(11 Pt 2):5617-24. PubMed ID: 4053035
[TBL] [Abstract][Full Text] [Related]
38. Benzo(a)pyrene metabolism and metabolites binding to DNA in the presence of BHA.
Sawicki J; Selkirk JK; Kugaczewska M; Piekarski L; McLeod MC
Arch Geschwulstforsch; 1980; 50(4):317-21. PubMed ID: 7458578
[TBL] [Abstract][Full Text] [Related]
39. Effects of dietary and in vitro 2(3)-t-butyl-4-hydroxy-anisole and other phenols on hepatic enzyme activities in mice.
Rahimtula AD; Jernström B; Dock L; Moldeus P
Br J Cancer; 1982 Jun; 45(6):935-44. PubMed ID: 7093125
[TBL] [Abstract][Full Text] [Related]
40. Dose-response studies of the effect of dietary butylated hydroxyanisole on colon carcinogenesis induced by methylazoxymethanol acetate in female CF1 mice.
Reddy BS; Maeura Y
J Natl Cancer Inst; 1984 May; 72(5):1181-7. PubMed ID: 6585593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
